The Foundation received some excellent news earlier this year that a manuscript from Dr Rishi Kotecha and his research team at the Telethon Kids Institute has been provisionally accepted for publication in a high impact journal.
The manuscript is being published in Haematologica, a journal for the broad field of hematology that reports on novel important findings in basic, clinical and translational research.
The manuscript came about from the team’s research project funded by CLCRF to identify novel therapeutic approaches for patients with high-risk infant leukaemia. The team has screened many new drugs and the manuscript focuses on how a particular drug, called Romidepsin, has shown benefits in pre-clinical models of infant leukaemia.
Being published in a high impact journal is important for scientists as it allows the dissemination of information discovered in the laboratory to the broader public of other scientists and other clinicians.
“Without this information being shared, it won’t be translated to the clinical setting. If everyone’s aware of the information that you discover, then they can translate it to have a direct effect on the patients with cancer.” Rishi says.
Important research projects like this would not be possible without the continued support and funding from CLCRF. “Without the support of CLCRF, our program would not exist essentially,” Rishi says. “Without the support that we get, we just wouldn’t be able to conduct the research we’re doing today.”
The Foundation would like to commend Rishi and his team for this excellent achievement. We look forward to continuing funding the research project and learning more about their developments in infant leukaemia research.